BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10

• Press Releases

  American Society of Hematology Accepts Telo Genomics’ Abstract for Presentation at its 2025 Meeting and Exposition

  Recognition highlights commercial potential of Telo’s telomere-based MRD technology in the growing precision oncology market

  October 9, 2025

   · 

  6 min read
• Press Releases

  OS Therapies Provides Positive EMA Regulatory Update Following Positive Rapporteur Meeting

  Overall survival recognized as key efficacy endpoint in osteosarcoma, where no standard of care exists Rapporteur highlights potential broader benefits of OST-HER2 in pulmonary and primary osteosarcoma settings, supported by translational canine data from the University of Pennsylvania

  October 9, 2025

   · 

  6 min read
• Press Releases

  InMed Pharmaceuticals Appoints Mr. Neil Klompas to It’s Board of Directors

  October 9, 2025

   · 

  4 min read
• Press Releases

  Hemostemix Files for Ethics Approval of its Study of Vascular Dementia

  October 9, 2025

   · 

  12 min read
• Press Releases

  Global Hemp Group Applies for Partial Revocation Order and Announces Proposed Financing

  October 9, 2025

   · 

  5 min read
• Press Releases

  L7 Informatics Claims that Ontology is the New Digital Backbone of Life Sciences

  October 9, 2025

   · 

  1 min read
• Press Releases

  Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

  $4 million upfront with up to additional $12 million of potential aggregate gross proceeds upon the exercise in full of warrants

  October 9, 2025

   · 

  5 min read
• Press Releases

  Data Analyses Show Benefit for Individuals With Infantile-Onset Niemann-Pick Disease Type C Treated With Investigational Drug Adrabetadex

  October 9, 2025

   · 

  6 min read
• Press Releases

  Stoke Therapeutics and Biogen Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome

  October 9, 2025

   · 

  14 min read
• Press Releases

  Vir Biotechnology Announces First Patient Dosed in Part 3 of Phase 1 Trial of PSMA-Targeting PRO-XTEN® Dual-Masked T-Cell Engager VIR-5500 in Combination with Androgen Receptor Pathway Inhibitors for the Treatment of Metastatic Prostate Cancer

  October 9, 2025

   · 

  7 min read